Zostavax (Zoster Vaccine, Live)

Detailed View: Safety Labeling Changes Approved By FDA Center for Biologics Evaluation and Research (CBER)   February 2016 ADVERSE REACTIONS Postmarketing Eye Disorders: necrotizing retinitis (patients on...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts